BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

543963

SHELTER

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SHELTER PHARMA LIMITED Share Price Update

As of the latest trading session, SHELTER PHARMA LIMITED share price is currently at ₹ 45, which is down by ₹ -1.50 from its previous closing. Today, the stock has fluctuated between ₹ 45.00 and ₹ 45.00. Over the past year, SHELTER PHARMA LIMITED has achieved a return of -17.02 %. In the last month alone, the return has been 1.05 %. Read More...

Investment Returns

Over 1 Month 1.05% Over 3 Months 3.49% Over 6 Months 2.15% Over 1 Year -17.02%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SHELTER PHARMA LIMITED fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    52.00

  • P/E Ratio (TTM)

    7.19

  • Beta

    0.86

  • Book Value / share

    36.14

  • Return on equity

    25.58%

  • EPS (TTM)

    6.26

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

SHELTER PHARMA LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 50.66
Operating Expense 40.99
Net Profit 7.24
Net Profit Margin (%) 14.29
Earnings Per Share (EPS) 6.26
EBITDA 10.08
Effective Tax Rate (%) 25.20
Particulars MAR 2024 (Values in Cr)
Revenue 40.02
Operating Expense 31.75
Net Profit 6.20
Net Profit Margin (%) 15.49
Earnings Per Share (EPS) 5.36
EBITDA 8.58
Effective Tax Rate (%) 25.12
Particulars MAR 2023 (Values in Cr)
Revenue 36.15
Operating Expense 28.27
Net Profit 5.21
Net Profit Margin (%) 14.41
Earnings Per Share (EPS) 6.72
EBITDA 7.15
Effective Tax Rate (%) 25.50
Particulars MAR 2022 (Values in Cr)
Revenue 30.06
Operating Expense 27.56
Net Profit 1.84
Net Profit Margin (%) 6.12
Earnings Per Share (EPS) 37.96
EBITDA 2.68
Effective Tax Rate (%) 26.69
Particulars MAR 2021 (Values in Cr)
Revenue 22.48
Operating Expense 22.73
Net Profit -0.24
Net Profit Margin (%) -1.06
Earnings Per Share (EPS) -5.08
EBITDA -0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 30.17
ROE % 25.58
ROCE % 33.54
Total Debt to Total Equity 0.05
EBITDA Margin 21.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.57
ROE % 55.27
ROCE % 68.12
Total Debt to Total Equity 0.09
EBITDA Margin 22.54
Particulars MAR 2022 (Values in Cr)
Book Value / Share 162.45
ROE % 29.37
ROCE % 40.45
Total Debt to Total Equity 0.01
EBITDA Margin 10.15
Particulars MAR 2021 (Values in Cr)
Book Value / Share 127.48
ROE % 0.66
ROCE % 1.28
Total Debt to Total Equity 0.02
EBITDA Margin 0.89
Particulars MAR 2020 (Values in Cr)
Book Value / Share 131.03
ROE % 1.35
ROCE % 1.92
Total Debt to Total Equity 0.04
EBITDA Margin 0.83
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.03
Total Assets 37.91
Total Liabilities 37.91
Total Equity 35.81
Share Outstanding 11558792
Price to Book Ratio 1.63
Return on Assets (%) 16.35
Return on Capital (%) 17.04
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.42
Total Assets 21.44
Total Liabilities 21.44
Total Equity 14.54
Share Outstanding 7743792
Price to Book Ratio 0.00
Return on Assets (%) 24.27
Return on Capital (%) 31.87
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 12.83
Total Liabilities 12.83
Total Equity 8.80
Share Outstanding 483987
Price to Book Ratio 0.00
Return on Assets (%) 16.03
Return on Capital (%) 23.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 10.20
Total Liabilities 10.20
Total Equity 7.11
Share Outstanding 483987
Price to Book Ratio 0.00
Return on Assets (%) 0.40
Return on Capital (%) 0.58
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 10.63
Total Liabilities 10.63
Total Equity 6.98
Share Outstanding 453987
Price to Book Ratio 0.00
Return on Assets (%) 0.75
Return on Capital (%) 1.11
Particulars MAR 2024 (Values in Cr)
Net Income 8.40
Cash from Operations -0.28
Cash from Investing -4.54
Cash from Financing 11.00
Net change in Cash 4.61
Free Cash Flow 0.57
Particulars MAR 2023 (Values in Cr)
Net Income 7.88
Cash from Operations 0.00
Cash from Investing 0.11
Cash from Financing 0.21
Net change in Cash 0.32
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income 2.80
Cash from Operations 0.51
Cash from Investing -0.85
Cash from Financing 0.06
Net change in Cash -0.27
Free Cash Flow 1.12
Particulars MAR 2021 (Values in Cr)
Net Income 0.06
Cash from Operations -0.28
Cash from Investing 0.03
Cash from Financing 0.48
Net change in Cash 0.23
Free Cash Flow -0.27
Particulars MAR 2020 (Values in Cr)
Net Income 0.10
Cash from Operations -0.27
Cash from Investing 0.28
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow -0.21
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.40 12.82 1.71 240.63 30.00 / 69.50
BLISS GVS PHARMA LTD 155.80 15.41 1.56 1643.65 105.05 / 190.65
CIPLA LTD 1589.65 23.81 4.11 128404.63 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 317.55 8.94 2.57 934.58 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2783.45 49.79 24.16 47153.32 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.40 17.07 4.96 240.63 30.00 / 69.50
AMRUTAJAN HEALTH LTD 688.80 36.52 6.09 1991.36 548.05 / 840.55
ASTRAZENECA PHARMA IND LT 8469.45 100.12 27.48 21173.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 155.80 23.29 1.55 1643.65 105.05 / 190.65

SHELTER PHARMA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
45.00 -3.22 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 46.30
  • 26 Days 44.90
  • 10 Days 46.00
  • 50 Days 44.00
  • 12 Days 45.90
  • 100 Days 43.90
  • 20 Days 45.30
  • 200 Days 45.60
46.50 PIVOT

First Support

46.49

First Resistance

46.50

Second Support

46.49

Second Resistance

46.51

Third Support

46.48

Third Resistance

46.51

RSI

50.42

ADX

28.25

MACD

0.93

Williams % R

-58.82

Commodity Channel Index (CCI)

15.79

Date

2025-08-28

Week

16200.00

Same Day

6000.00

Month

16571.00

1 Year

0.86

3 Year

0.77

Over 1 Month

1.05%

down

Over 1 Year

-17.02%

down

Over 3 Months

3.49%

down

Over 3 Years

2.35%

down

Over 6 Months

2.15%

down

Over 5 Years

0.00%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

SHELTER PHARMA LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

SHELTER PHARMA LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
23 Sep 2024 0.33 Final 23 Sep 2024 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SHELTER PHARMA LIMITED Share Price

Shelter Pharma Limited originally named as 'Shelter Pharmacy', was converted from a Partnership Firm 'M/s Shelter Pharma' to a Public Limited Company under the name 'Shelter Pharma Limited' on 12 October, 2007 with the Registrar of Companies, Gujarat.

The Company primarily focuses in manufacturing of ayurvedic and herbal products with well-built presence in Human Pharma as well as Veterinary space. The Company started with a few products about decades back. However, over a period of time, it has added products to portfolio through in-house R & D efforts backed by sound knowledge of Ayurveda.

The business was slowly expanded from local presence in Himmatnagar to well spread presence in the State of Gujarat. The Company remained a family enterprise before incorporation of the Company with a consolidated position in Gujarat. Introduction of new generation of promoters, set up of new companies around 2007 brought new ideas and aspirations to the business.

The Company has reworked its organizational structure, product portfolio, distribution network, pricing, packaging and internal processes. It also invested substantially in strengthening infrastructure with fresh fund infusion to improve its manufacturing capacity in Himmatnagar. Apart from these, it sources required raw material from nearby villages, directly from farmers. It has long relationships with farmers, giving an assured supply of herbs and plants. It focuses on rural/semi urban market as its clientele to offer high quality price competitive remedies to villages.

As of now, the Company is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. It enjoys a good product acceptance and market share in the State of Gujarat. In the Human pharma segment, the Company has product portfolio of OTC products as well Ethical pharma products. Similarly, it has OTC and Ethical presence in Veterinary segment. It has a respectable track record of efficacy of its products. Presently, it is moving aggressively to tap these opportunities with geographical expansion backed by intense marketing & branding efforts.

The Company launched Nutraceuticals product like Emune 19, D3 Cure, Beta Glucan, Ferro cure etc. in 2021.

The Company made an Initial Public Offer (IPO) and allotted a fresh issue of 38,16,000 Equity Shares of face value of Rs 10 each by raising funds aggregating to Rs 16.02 Crore in August, 2023.

Parent organization Indian Private
NSE symbol [-]
Founded 2007
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Shelter Pharma Ltd?

Answer Field

Shelter Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 45.00 as on Aug 29 2025 01:58 PM.

What is the Market Cap of Shelter Pharma Ltd Share?

Answer Field

The market cap of Shelter Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 52.00 as on Aug 29 2025 01:58 PM.

What is the 52 Week High and Low of Shelter Pharma Ltd?

Answer Field

The 52 Week High and Low of Shelter Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 69.70 and ₹ 35.70.

What is 1 year return for Shelter Pharma Ltd?

Answer Field

The 1 year returns on the stock has been -17.02%.

What is the P/E Ratio of Shelter Pharma Ltd Share?

Answer Field

As on Aug 29 2025 01:58 PM the price-to-earnings (PE) ratio for Shelter Pharma Ltd share is 7.19.

What is the PB ratio of Shelter Pharma Ltd Share?

Answer Field

As on Aug 29 2025 01:58 PM, the price-to-book (PB) ratio for Shelter Pharma Ltd share is 36.14.

How to Buy Shelter Pharma Ltd Share?

Answer Field

You can trade in Shelter Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shelter Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Shelter Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shelter Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91